NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Cardiac Troponin Diagnostics Market Growth Boosted by High-sensitivity Point-of-care Testing Says Frost & Sullivan - The rise in emergency department visits due to cardiac complaints drives the demand for cTn biomarkers
Cardiac Troponin Diagnostics Market Growth Boosted by High-sensitivity Point-of-care Testing Says Frost & Sullivan

 

NewswireTODAY - /newswire/ - San Antonio, TX, United States, 2022/11/30 - The rise in emergency department visits due to cardiac complaints drives the demand for cTn biomarkers.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The global demand for cardiac troponin (cTn) diagnostics biomarkers is increasing as more patients with cardiac complaints are visiting emergency departments (EDs), according to Frost & Sullivan’s recent analysis of the cTn diagnostics market. The sector is driven by hospitals and clinical laboratories adopting high-sensitivity (hs)-cTn assays, which can detect troponin in lower concentrations and significantly shorten the timeline for myocardial infarction (MI) detection. The global market for cTn diagnostics is expected to reach $2.28 billion by 2025, up from $2.07 billion in 2021, representing a 2.4% compound annual growth rate.

“An increasing need for rapid and reliable cTn diagnostics tests in EDs to mitigate urgent response challenges for a positive test result is noticeable,” said Utkarsha Kaustubh Soundankar, Healthcare Research Analyst at Frost & Sullivan. “The dynamics will boost the market revenue for POC tests during the forecast period.”

Soundankar added: “Point-of-care testing (POCT) is rapidly gaining traction globally and reduces turnaround time and the length of stay in the ED. Additionally, POC troponin assays can offer test results within 20 minutes, and doctors can use them for diagnosis in remote settings and the ED.”

To reap the benefits of the growing cTn diagnostics industry, market participants should:

• Develop rapid and easy-to-use diagnostic tests targeting EDs, as decreasing turnaround times in EDs can significantly reduce healthcare costs.
• Invest in research and development for hs-cTn because it can provide rapid diagnostic tests and reduce the probability of false positives.
• Work with scientists to develop applications and software platforms that can integrate with devices to get real-time data and increase the speed and efficiency of the diagnostic process.
• Focus on educating and empowering patients and clinicians in newer diagnostic technologies and accurate usage to prevent false positives.

Cardiac Troponin Diagnostics Forecasts and Opportunities to 2025 is the latest addition to Frost & Sullivan’s Healthcare research and analyses available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.

About Frost & Sullivan

For over six decades, Frost & Sullivan (frost.com) has helped build sustainable growth strategies for Fortune 1000 companies, governments, and investors. We apply actionable insights to navigate economic changes, identify disruptive technologies, and formulate new business models to create a stream of innovative growth opportunities that drive future success. Contact us: Start the discussion

Cardiac Troponin Diagnostics Forecasts and Opportunities to 2025 / PDB7

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Cardiac Troponin Diagnostics Market Growth Boosted by High-sensitivity Point-of-care Testing Says Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Cardiac Troponin Diagnos. | Frost & Sullivan
Contact: María Celeste Bailo - Frost.com 
877-463-7678 celeste.bailo[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

Withings and Function Connect Daily Health Measurements with Advanced Lab Testing
SCHOTT Pharma and Nemera Launch First Fully Compatible Large-volume Passive Safety System with Prefillable Glass Syringe
SleepRes Receives Frost & Sullivan’s 2026 North America New Product Innovation Recognition For Excellence In Positive Airway Pressure Device
Withings Rolls Out Glucose Resilience - A New Metabolic Wellness Score Available on BodyScan 2
Bruker Advances Whole-Organism 3D Imaging with Enhanced Tissue-Clearing Workflows
Withings BodyScan 2 Now Available in the US - Setting a Standard in Preventive Health and Longevity Monitoring
Withings Launches Withings Medical, Bringing Clinical Care to Medicare-Eligible Patients Under CMS's New ACCESS Model
Bruker Launches D8 ADVANCE HE and D8 DISCOVER HE High-Energy XRD Systems for Batteries, Amorphous Materials, and Catalysts
Withings Acquires Biosency and Enters Respiratory Remote Monitoring
Bruker Launches Two Novel Mass Spectrometry Systems for Unique Applications in Energy Industry Research, and in Semiconductor Manufacturing
Institut Curie, the CEA and Thales Sign a Partnership to Build a Unique FLASH Radiotherapy Platform to Accelerate the Cure for Cancers
Royal Healthcare in Singapore Provides NEC's 'FonesVisuas Test' for Disease Risk Prediction
Bruker Showcases Analytical and Automation Innovations for Applied, Biopharma, Industrial and Academic Markets At Analytica 2026
Bruker Showcases Extended Automation in Biophysics SLAS2026
SCHOTT Pharma Polymer Cartridge Platform Compatible with Large-volume SHL Medical Autoinjectors

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit BizJobs.com

Visit  JobsWare.com





 
  ©2005-2026 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS | 
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)